Table 2 shows baseline clinical and laboratory characteristics of the participants in public health facilities, Southern Ethiopia, 2018
Variables | Category of variables | Follow up status | Total n (%) | |||
|---|---|---|---|---|---|---|
Active n (%) | Lost for FU n (%) | Transfer out n (%) | Dead n (%) | |||
Weight | ≤ 40 | 26 (5.7) | 8 (1.8) | 6 (1.3) | 4 (1.1) | 44 (9.7) |
40.1–50 | 107 (23.5) | 14 (3.2) | 12 (2.6) | 14 (3.1) | 147 (32.3) | |
50.1–60 | 104 (22.8) | 32 (7) | 16 (3.5) | 14 (3.1) | 166 (36.5) | |
> 60 | 62 (13.6) | 24 (5.3) | 10 (2.2) | 2 (0.4) | 98 (21.5) | |
CD4 count | ≤ 100 | 23 (5.1) | 8 (1.7) | 9 (2) | 10 (2.2) | 50 (11.1) |
101–200 | 43 (9.4) | 11 (2.4) | 12 (2.6) | 5 (1.1) | 71 (15.6) | |
> 200 | 233 (51.2) | 59 (13) | 23 (5.1) | 19 (4.2) | 334 (73.4) | |
Anemia | No anemia | 159 (34.9) | 27 (5.9) | 13 (2.8) | 13 (2.9) | 212 (46.6) |
Mild | 76 (16.7) | 21 (4.6) | 16 (3.5) | 6 (1.3) | 119 (26.2) | |
Moderate | 55 (12.1) | 25 (5.5) | 15 (3.3) | 5 (1.1) | 100 (22) | |
Sever | 9 (2) | 5 (1.1) | 0 | 10 (2.2) | 29 (6.4) | |
BMI | ≥ 18.5 | 219 (48.1) | 56 (12.3) | 20 (4.4) | 17 (3.7) | 312 (68.6) |
16–18.4 | 54 (11.9) | 18 (4) | 14 (3.1) | 11 (2.4) | 97 (21.3) | |
< 16 | 26 (5.7) | 4 (0.9) | 10 (2.2) | 6 (1.3) | 46 (10.1) | |
INH Prophylaxis CPT | Yes | 256 (56.3) | 59 (13) | 26 (5.7) | 17 (3.7) | 358 (78.7) |
No | 43 (9.5) | 19 (4.2) | 18 (4) | 17 (3.7) | 97 (21.3) | |
Yes | 235 (51.6) | 59 (13) | 40 (8.8) | 30 (6.6) | 364 (80) | |
No | 64 (14.1) | 19 (4.2) | 4 (0.9) | 4 (0.9) | 91 (20) | |
WHO clinical staging | I | 142 (31.2) | 31 (6.8) | 13 (2.8) | 4 (0.9) | 190 (41.7) |
II | 60 (13.2) | 19 (4.2) | 7 (1.5) | 7 (1.5) | 93 (20.4) | |
III | 82 (18) | 25 (5.5) | 18 (4) | 13 (2.9) | 138 (30.5) | |
IV | 15 (3.3) | 3 (0.7) | 6 (1.3) | 10 (2.2) | 34 (7) | |
Adherence | Good | 268 (58.9) | 40 (8.8) | 41 (9.1) | 19 (4.2) | 368 (80.9) |
Fair | 16 (3.5) | 6 (1.3) | 0 | 0 | 22 (4.8) | |
Poor | 15 (3.3) | 32 (7) | 3 (0.7) | 15 (3.3) | 65 (14.3) | |
Functional status | Working | 217 (47.7) | 56 (12.3) | 27 (5.9) | 10 (2.2) | 310 (68.1) |
Ambulatory | 76 (16.7) | 18 (3.9) | 11 (2.4) | 12 (2.6) | 117 (25.7) | |
Bedridden | 6 (1.3) | 4 (0.9) | 6 (1.3) | 12 (2.2) | 28 (6.2) | |
Substance use | Yes | 43 (9.4) | 17 (3.73) | 15 (3.29) | 12 (2.63) | 87 (19.1) |
No | 256 (56.2) | 61 (13.4) | 29 (6.4) | 22 (4.8) | 368 (80.9) | |
Evidence of TB at start of ART | Yes | 32 (7.1) | 7 (1.5) | 8 (1.5) | 21 (4.6) | 67 (14.7) |
No | 267 (58.7) | 71 (15.6) | 37 (8.1) | 13 (5.1) | 388 (85.3) | |